[1]
Tighiouart, M. et al. 2022. Modeling synergism in early phase cancer trials with drug combination with continuous dose levels: is there an added value?. REVISTA BRASILEIRA DE BIOMETRIA. 40, 4 (dez. 2022), 453–468. DOI:https://doi.org/10.28951/bjb.v40i4.627.